Giant Biogene Holding (HKG:2367) is targeting to raise HK$2.33 billion through a top-up placement, according to a Thursday disclosure.
Juzi Holding, the firm's controlling shareholder, is selling its 35 million shares in the company at HK$66.65 apiece.
The manufacturer of professional skin treatment products will then issue new shares to Juzi Holding, which agreed to subscribe for the exact number of shares it sold at the same price.
Upon completion of the deals, Juzi's stake in Giant Biogene will fall to 54.26% from 56.10%.
Deal proceeds will go towards marketing, category expansion, overseas business and research and development, and general corporate purposes.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.